title: How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients.
abstract: BACKGROUND
  This study aims to determine the use of preoperative clinical, biochemical, and cross-sectional imaging features for predicting malignancy in cystic lesions of the pancreas (CLP).
  
  
  METHODS
  Two hundred twenty patients who underwent operations for CLP or suspected CLP were reviewed. Patients were divided into two groups, patients undergoing operations for pseudocysts and patients undergoing operations for suspected cystic neoplasms. The predictive effect of various preoperative factors on the malignant potential of CLP was evaluated.
  
  
  RESULTS
  Forty-four patients with a preoperative diagnosis of pseudocysts underwent operations for complications of pseudocyst. Forty-two were confirmed pathologically to have pseudocysts, but two were found, unexpectedly, to harbor malignant lesions. One hundred seventy-six patients underwent operations for suspected pancreatic cystic neoplasms. There were 70 benign, 51 potentially malignant, and 55 malignant CLP. On multivariate analysis, three factors, ie, elevated serum carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9; cyst size > 3 cm; and presence of one or more of three morphologic features, such as solid component; peripheral calcification; and main duct dilation on cross-sectional imaging were independent predictors of malignancy. Presence of two or three of these factors had a positive predictive value of 88% in predicting a premalignant or malignant CLP.
  
  
  CONCLUSIONS
  Most pancreatic pseudocysts can be accurately diagnosed preoperatively. In patients with suspected pancreatic cystic neoplasms, elevated serum CEA or carbohydrate antigen 19-9, cyst size > 3 cm, and presence of suspicious morphologic features on imaging are predictors of potentially malignant or malignant CLP. Patients with a high likelihood of a potentially malignant or malignant lesion based on these three factors should undergo operation without additional investigations.
authors.affiliation: Department of Surgery, Singapore General Hospital, Singapore.
authors.forename: Brian K P
authors.initials: BK
authors.lastname: Goh
authors.forename: Yu-Meng
authors.initials: YM
authors.lastname: Tan
authors.forename: Choon-Hua
authors.initials: CH
authors.lastname: Thng
authors.forename: Peng-Chung
authors.initials: PC
authors.lastname: Cheow
authors.forename: Yaw-Fui Alexander
authors.initials: YF
authors.lastname: Chung
authors.forename: Pierce K H
authors.initials: PK
authors.lastname: Chow
authors.forename: Wai-Keong
authors.initials: WK
authors.lastname: Wong
authors.forename: London L P J
authors.initials: LL
authors.lastname: Ooi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018395:CA-19-9 Antigen / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010180:Pancreatectomy / Q000379:methods*; D010181:Pancreatic Cyst / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D010192:Pancreatic Pseudocyst / Q000097:blood / Q000175:diagnosis / Q000601:surgery; D011230:Precancerous Conditions / Q000175:diagnosis* / Q000601:surgery; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012846:Singapore; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen